Marisca Marian | Global Access Strategy Lead, Oncology
Bayer

Dr Marisca Marian is a dynamic and results-driven professional with a proven track record in the pharmaceutical industry. Currently serving as the Global Access Strategy Lead for Oncology at Bayer, Marisca is at the forefront of shaping access strategies that ensure patients have timely and affordable access to life-saving treatments. With a deep understanding of the complexities of the healthcare landscape, Marisca leverages her expertise to navigate HTA and reimbursement challenges, ultimately driving positive outcomes for both patients and the organization.

With a background in  Medical Oncology and healthcare economics & market access, Marisca brings a unique perspective to her role, combining analytical rigor with a patient-centric approach. Her strategic mindset and collaborative leadership style have enabled her to successfully lead cross-functional teams and forge strong partnerships with key stakeholders in the healthcare ecosystem.

Marisca is passionate about driving innovation in access strategies and leveraging real-world evidence to demonstrate the value of oncology treatments. Her commitment to advancing healthcare access aligns with Bayer's mission to improve the lives of people worldwide. As a speaker at the World EPA Congress 2026, Europe’s Leading Healthcare Pricing, Access, and Evidence Congress, Marisca will share her insights and expertise on navigating the evolving landscape of healthcare access & RWE, offering valuable perspectives for industry professionals seeking to drive positive change in healthcare systems.